A critical discovery in cancer research is emerging with the use of VHH fragments to reactivate mutated p53. This essential malignant suppressor protein is frequently disabled in various kinds of malignancies, https://bookmarkcolumn.com/story21734322/nanobodies-reactivate-the-p53-protein-the-potential-hope-for-malignant-treatment